Course Directors


William F. Northrup III, MD, FAHA, FACC
Cardiovascular, Thoracic Surgeon
Vice President, Physician Relations
and Education


Marc H. Glickman, MD, FACS
Chief of Vascular Surgery
Sentara Healthcare



Central Venous Pathology Summit March 25-27, 2014

CryoLife Headquarters, Kennesaw, Georgia

 Agenda and Faculty List

The Central Venous Pathology (CVP) Summit will examine the algorithms for durable dialysis access related to central venous pathology through an interactive data-driven and clinically-focused didactic and a hands-on wet lab practicum.

I. Didactic Sessions (All Specialities)

II. Wet-Lab Sessions (Hands-On)

  1. Central Venous Anatomy in a Human Cadaver
  2. HeRO® Graft Implantation




CVP Summit Review

On November 6-8, 2013, the second Central Venous Pathology Summit took place at CryoLife’s training facility at its corporate headquarters in suburban Atlanta and at the St. Joseph Translational Research Institute in Atlanta, Georgia. In attendance were 75 physicians and dialysis therapy professionals.

The aim of the Summit was to examine treatment strategies for durable hemodialysis access in cases of central venous pathology through an interactive, data-driven and clinically-focused didactic and hands-on wet lab practicum.

The presentations and discussions focused on the cause and scope, as well as the prevention and management of central venous pathology. In addition, the Summit featured in-depth sessions on the HeRO® (Hemodialysis Reliable Outflow) Graft, including clinical presentations and a live implantation. As part of this Summit, CryoLife also invited several private companies with emerging technology related to central venous stenosis and durable hemodialysis access to make presentations.

The course co-directors were William Northrup III, MD, Vice President of Physician Relations and Education at CryoLife and Marc H. Glickman, MD, FACS, chief of vascular surgery at Sentara Healthcare.

Additional Faculty included Jeffrey H. Lawson, MD, PhD, Vascular Surgeon Professor of Surgery, Duke University Medical Center; Stephen E. Hohmann, MD, FACS, Vascular Surgeon, Baylor Heart and Vascular Hospital; Christopher J. Marrocco, MD, Vascular Surgeon, Memorial Health Care System; John R. Ross, MD, General Surgeon, The Regional Medical Center; Christie W. Gooden, MD, Transplant Surgeon, St. Luke’s Health System; Jeffrey G. Hoggard, MD, FACP, FASN, Interventional Nephrologist, Duke Raleigh Hospital; John C. Gurley, MD, Interventional Cardiologist, University of Kentucky Medical Center; Charles Y. Kim, MD, Assistant Professor of Radiology, Duke University Medical Center; Shawn M. Gage, PA-C, AAPA, AASPA, PAEA, Senior Physician Assistant, Vascular Surgery, Duke University Medical Center; Deborah J. Brouwer-Maier, RN, CNN, Director, Clinical Operations, Fresenius Vascular Care.




The program participant is responsible for compliance with individual conflict of interest or other institutional policies as well as any state regulations regarding industry sponsored educational events and associated expenses that may apply to participant. Please note that certain expenditures made by CryoLife in conjunction with your attendance may be reported pursuant to the Physician Payment Sunshine Act.